Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M1–M5 Muscarinic Receptor Knock-Out Mice

Keywords

Oxotremorine, Muscarinic acetylcholine receptor, Muscarinic acetylcholine receptor M4, Dopamine, Dopaminergic

References

• Antimuscarinic drugs in the treatment of movement disorders.Stanley Fahn, Robert E. Burke, Yaakov Stern — 1990
• Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genesVéronique Bernard, Elisabeth Normand, Bertrand Bloch — 1992
• Regulation of the Subcellular Distribution of m4 Muscarinic Acetylcholine Receptors in Striatal Neurons In Vivo by the Cholinergic Environment: Evidence for Regulation of Cell Surface Receptors by Endogenous and Exogenous StimulationVéronique Bernard, Allan I. Levey, Bertrand Bloch — 1999
• Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype- specific antibodiesSM Hersch, CA Gutekunst, HD Rees — 1994
• Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out MiceWeilie Zhang, Anthony S. Basile, Jesús Gomeza — 2002
• Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodiesAllan I. Levey, C. A. Kitt, WF Simonds — 1991
• Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.M Raiteri, Riccardo Leardi, Mario Marchi — 1984
• Muscarinic receptors--characterization, coupling and function.Malcolm P. Caulfield — 1993
• Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and leanMasahisa Yamada, Tsuyoshi Miyakawa, Alokesh Duttaroy — 2001
• Interacting Presynaptic k‐Opioid and GABAA Receptors Modulate Dopamine Release from Rat Striatal SynaptosomesEric Ronken, A.H. Mulder, Anton N. M. Schoffelmeer — 1993
• Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals.Mario Marchi, Paola Sanguineti, Maurizio Raiteri — 1990
• Muscarinic Modulation of Striatal Dopamine, Glutamate, and GABA Release, as Measured with In Vivo MicrodialysisIlse Smolders, Liesbeth Bogaert, Guy Ebinger — 1997
• Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions.G. Di Chiara, Micaela Morelli, S. Consolo — 1994
• Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.John Lehmann, S.Z. Langer — 1982
• Neurotransmitters and neuromodulators in the basal ganglia.Ann M. Graybiel — 1990
• Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.Nina De Klippel, Sophie Sarre, Guy Ebinger — 1993
• Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function.Satoshi Kaneko, Takatoshi Hikida, Dai Watanabe — 2000
• Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype.M. Matsui, Daisuke Motomura, Hiroshi Karasawa — 2000
• Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.Jesús Gomeza, Harlan E. Shannon, Evi Kostenis — 1999
• Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry.M. Teresa Vilaró, JoséM. Palacios, Guadalupe Mengod — 1990

Cited by

• Novel muscarinic receptor mutant mouse models.Jürgen Wess — 2012
• Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.Christina E. Brandt — 2009
• The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.L. A. Alves, Álvaro José Damião, Luís César Fontana — 2011
• Section I. The cholinergic system.John Smythies — 2005
• Muscarinic receptors in schizophrenia: is there a role for synaptic plasticity?Thomas J. Raedler — 2004
• Cholinergic interneurons and synaptic reorganization within the nucleus accumbens shell and core: Potential neural substrates underlying drug addictionMonica L. Berlanga — 2006
• Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Effect of dose and test environment.S Gralewicz, Piotr Lutz, Dorota Wiaderna — 2003
• Muscarinic mechanisms in psychotic disorders.David L. McKinzie, Frank P. Bymaster — 2012
• Chronic treatment with simvastatin affects cannabinoid receptor type 1 and muscarinic receptors type 2/4 in different brain regions among sham and 6-hydroxydopamine lesioned ratsNikolce Mackovski — 2013
• Neurotrophic factors modulation by adenosine receptors and dopamine release in the rat striatumCatarina Alexandra dos Reis Vale Gomes — 2009
• Allosteric interactions at the M3 muscarinic acetylcholine receptorLaura Iarriccio Silva — 2008
• Muscarinic agonists and antagonists in schizophrenia: recent therapeutic advances and future directions.Amanda R. Bolbecker, Anantha Shekhar — 2012
• Association Study of CHRM2 Polymorphisms with Substance-Use Pathology and Personality TraitsRobert M. Kirkpatrick — 2011
• Impact of species variability and ‘probe‐dependence’ on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptorSuraya Suratman, Katie Leach, Patrick M. Sexton — 2011
• Acute β-Amyloid Administration Disrupts the Cholinergic Control of Dopamine Release in the Nucleus AccumbensStefania Preda, Stefano Govoni, Cristina Lanni — 2008
• Muscarinic receptor subtype pharmacology and physiology.Richard M. Eglen — 2005
• Functional neurochemistry of the basal ganglia.Pershia Samadi, Claude Rouillard, Paul J. Bédard — 2007
• M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologiesEleni T. Tzavara, Frank P. Bymaster, Richard J. Davis — 2004
• Release‐enhancing pre‐synaptic muscarinic and nicotinic receptors co‐exist and interact on dopaminergic nerve endings of rat nucleus accumbensMassimo Grilli, Laura Patti, Federica Robino — 2008
• Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmissionRichard Exley, Stephanie J. Cragg — 2008

Related papers

• Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review.Jürgen Wess, Alokesh Duttaroy, Jesús Gomeza — 2003
• Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.Marie L. Woolley, Helen J. Carter, Jane Gartlon — 2009
• Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.Jesús Gomeza, Harlan E. Shannon, Evi Kostenis — 1999
• A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type.Kiyoyuki Kitaichi, Jamie C. Day, Rémi Quirion — 1999
• Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3.Maria C. Olianas, Abdu Adem, Evert Karlsson — 1998
• Down-regulation and desensitization of the muscarinic M1 and M2 receptors in transfected fibroblast B82 cells.Hong-Bing Wei, Henry I. Yamamura, William R. Roeske — 1994
• Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.Alokesh Duttaroy, Jesús Gomeza, Jai-Wei Gan — 2002
• Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M2 receptors.Seyed Khosrow Tayebati, A. Piergentili, David R.C. Natale — 1999
• Muscarinic receptor regulation and 2nd messenger responses in rat neocortex cultures.F. van Huizen, J.A.D.M. Tonnaer — 1993